US Open Note – Stocks soar; dollar continues to slip as US yields fall

US dollar back to losses

A downside move in the US dollar and the significant climb in US stock futures are the major themes of the day. The question is if this recovery is being driven by the fall in US yields after the milder-than-feared US CPI data. The US dollar index is approaching the 91.60 level, while dollar/yen is in the process of completing the third straight negative day around 109.00. Futures tracking the S&P 500, Nasdaq 100 and Dow Jones were pointing to a slight positive open, after record closes for the S&P 500 and the Nasdaq yesterday.

JPMorgan Chase (JPM) reported earning results on Wednesday that propelled past estimates. The largest US bank gained $14.3 billion in net income from $11.4 billion the previous year, driven by credit reserve releases of $5.2 billion.

Euro bulls pick up steam as dollar struggles

The European Union is ready to activate a five-year dept plan of €800 billion by September to recover from the coronavirus pandemic, mainly by selling bonds and bills. Euro/dollar has finally breached the wall around the 40-day simple moving average (SMA) and is set to meet the key resistance of 1.1985, while euro/yen is struggling around the 130.30 level.

Meanwhile, euro/pound is holding around 0.8680, after a rebound off 0.8470 in the previous week. Pound/dollar is climbing from the 1.3670 significant support. Pound/yen may gather interest in the coming sessions as the pair is falling beneath the short-term SMAs, crossing below 150.00.

Aussie, kiwi and oil return to positive mode

In the commodity currencies, aussie/dollar is posting notable gains, trying to reach the 0.7700 round number, while kiwi/dollar surpassed the 0.7100 psychological mark. However, dollar/loonie is still in a horizontal move around 1.2560.

Elsewhere, oil prices are heading north after several flat days, with WTI meeting the $61/per barrel zone and the gold price continues the sideways move near $1,743/per ounce.

Johnson & Johnson vaccine linked with cases of clotting?

In the US, there are a lot of concerns about links of clotting from the Johnson & Johnson Covid-19 vaccine, pausing the vaccination, with the company then agreeing to postpone the launch in Europe as well.

In the Netherlands, Prime Minister Rutte stated that lockdown measures will continue at least until April 28 as the coronavirus. Italy, Germany and France are going back into lockdown too and the Q2 outlook remains soft.

Later in the day, a speech by Fed Chair Powell at 17:00 GMT will be in focus before the Economic Club of Washington in a virtual event.

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

We are using cookies to give you the best experience on our website. Read more or change your cookie settings.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.